Established in 1994, Cell Marque Corporation primarily focuses on producing and marketing antibodies for diagnostic immunohistochemistry (IHC). Our main focus is providing quality and innovative antibodies for in vitro diagnostic use to further serve the clinical market.

Cell Marque serves pathology laboratories and research facilities globally through a domestic sales force, our team of Technical Consultants, as well as international distributors. We are a company that encourages intellectual growth and it is our goal to stay on top of current issues in our industry so that we can bring our customers the newest and most innovative antibodies available. In addition, Cell Marque manufactures and supplies primary antibodies to Ventana Medical Systems® (a member of The Roche Group) who is the world leader in automated IHC platforms.

Lastly, we are one of the only IHC companies that employs a team of medical doctors, including two full-time pathologists, to deliver to our customers the level of quality and support they deserve. Cell Marque operates out of a consolidated facility in Rocklin, California. The facility incorporates laboratories for hybridoma-derived antibody production, research and development, histology, and quality control as well as production floor space.

Cell Marque is both ISO13485:2003 certified and 21 CFR Part 820 compliant and therefore offers our products to key markets worldwide. We have also taken an initiative to enhance our productivity through studied improvements in workflow (LEAN Enterprise) and the adoption of paperless document management software.